US 8754223
Crystalline form of a biphenyl compound
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8754223 (Crystalline form of a biphenyl compound) held by Theravance, Inc. expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P35/00